Correlation Between Biofil Chemicals and Ortel Communications

Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Ortel Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Ortel Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Ortel Communications Limited, you can compare the effects of market volatilities on Biofil Chemicals and Ortel Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Ortel Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Ortel Communications.

Diversification Opportunities for Biofil Chemicals and Ortel Communications

0.18

Correlation Coefficient

Biofil Chemicals  Ortel Communications

Average diversification

The 3 months correlation between Biofil and Ortel is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Ortel Communications Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ortel Communications and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Ortel Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ortel Communications has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Ortel Communications go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Ortel Communications

Assuming the 90 days trading horizon Biofil Chemicals Pharmaceuticals is expected to generate 1.78 times more return on investment than Ortel Communications. However, Biofil Chemicals is 1.78 times more volatile than Ortel Communications Limited. It trades about -0.03 of its potential returns per unit of risk. Ortel Communications Limited is currently generating about -0.44 per unit of risk. If you would invest  5,924  in Biofil Chemicals Pharmaceuticals on October 21, 2024 and sell it today you would lose (179.00) from holding Biofil Chemicals Pharmaceuticals or give up 3.02% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.0%
Values	Daily Returns

Biofil Chemicals Pharmaceutica  vs.  Ortel Communications Limited

Biofil Chemicals Pha

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biofil Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Ortel Communications

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ortel Communications Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Biofil Chemicals and Ortel Communications

The main advantage of trading using opposite Biofil Chemicals and Ortel Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Ortel Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ortel Communications will offset losses from the drop in Ortel Communications' long position.

The idea behind Biofil Chemicals Pharmaceuticals and Ortel Communications Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.